Herbst Group »

Autolus Therapeutics Plc spon ads shares owned by Herbst Group

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Herbst Group from 13F filings

Historical chart of Herbst Group investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Herbst Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Herbst Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $91k 25k 3.63

More positions owned by Herbst Group

Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Us Aer Def Etf (ITA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alps Etf Tr Alerian Mlp (AMLP)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Select Sector Spdr Tr Energy (XLE)
NVIDIA Corporation (NVDA)
Vanguard Scottsdale Fds Vng Rus2000idx (VTWO)
Oneok (OKE)

View all positions for Herbst Group

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Deep Track Capital
Polygon Management
Armistice Capital
Frazier Life Sciences Management
Affinity Asset Advisors
BlackRock
BlackRock
T. Rowe Price Associates
Deerfield Management Company
Laurion Capital Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Stempoint Capital

View all funds holding Autolus Therapeutics Plc spon ads